Tokyo, June 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058234) titled 'Predictive method for assessing the efficacy of mosunetuzumab and epcoritamab' on June 27.
Study Type:
Observational
Primary Sponsor:
Institute - Osaka International Cancer Institute
Condition:
Condition - follicular lymphoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The first objective is to evaluate the predictive validity of peripheral T cell cytotoxicity in determining the therapeutic efficacy of mosunetuzumab and epcoritamab. The second objective is to assess the efficacy of tetracyclines in enhancing peripheral T cell cytotoxicity in vitro in patie...